OHSU

Kidney Cancer Clinical Trials

Cancer Site(s): kidney
Trial Type: All Studies
Study Status: Open
Doctor/Investigator: Any
Age Group: Any
Keywords:

Refine Search | Start New Search |   Download search results to Excel

Sort by   Showing 1 - 6 of 6 results   Show 


A Randomized Phase II Study of Afinitor (RAD001) vs. Sutent (Sunitinib) in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (...)
Doctor/Investigator: Chris Ryan
Trial Type: Treatment
Organization: Knight (OHSU)
Cancer Site: Kidney
Study Status: Open
Age Group: Adult
Knight Cancer Institute Number: SOL-10060-M

EVErolimus for Renal Cancer Ensuing Surgical Therapy, a Phase III Study
Doctor/Investigator: Chris Ryan
Trial Type: Treatment
Organization: Knight (OHSU)
Cancer Site: Kidney
Study Status: Open
Age Group: Adult
Knight Cancer Institute Number: SOL-11045-C

AREN0533: Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Doctor/Investigator: Suman Malempati
Trial Type: Treatment
Organization: Knight (OHSU)
Cancer Site: Kidney
Study Status: Open
Age Group: All
Knight Cancer Institute Number: SOL-07066-C

AREN0532: Treatment for Very Low, Low and Standard Rick Favorable Histology Wilms Tumors
Doctor/Investigator: Suman Malempati
Trial Type: Treatment
Organization: Knight (OHSU)
Cancer Site: Kidney
Study Status: Open
Age Group: All
Knight Cancer Institute Number: SOL-07067-C

AREN03B2: Renal Tumors Classification, Biology, and Banking Study
Doctor/Investigator: Suman Malempati
Trial Type: Screening/Diagnostic
Organization: Knight (OHSU)
Cancer Site: Kidney
Study Status: Open
Age Group: All
Knight Cancer Institute Number: SOL-07061-C

EVErolimus for Renal Cancer Ensuing Surgical Therapy, a Phase III Study
Doctor/Investigator: Charles Dibb
Trial Type: Treatment
Organization: Southern Oregon OCI - Medford
Cancer Site: Kidney
Study Status: Open
Age Group: Adult
Knight Cancer Institute Number: SOL-11045-C